Neurontin for Everything
How does a drug company take an unproven, worthless, and potentially dangerous drug like Neurontin, and turn it into a billion dollar blockbuster? Through deceit, lies, and bribery reports New York Times health writer and author Melody Peterson.
Peterson, in her book "Our Daily Meds," reveals the chicanery, pseudoscience and greed behind the marketing of many of today's well-known drugs.
The history of one drug in particular, Neurontin, shows just how deceitful, ruthless, and cold-hearted some drug executives can be. The original clinical studies evaluating the efficiency of Neurontin for treating epilepsy were less than impressive.
The studies not only showed that the drug was ineffective, and potentially dangerous, but that in 5-10% of patients it actually increased the frequency and severity of the epileptic seizures.
The FDA found the drug be worthless and had grave concerns over its potential dangers. But historically they cave in to … Read More